About this Author
DBL%20Hendrix%20small.png College chemistry, 1983

Derek Lowe The 2002 Model

Dbl%20new%20portrait%20B%26W.png After 10 years of blogging. . .

Derek Lowe, an Arkansan by birth, got his BA from Hendrix College and his PhD in organic chemistry from Duke before spending time in Germany on a Humboldt Fellowship on his post-doc. He's worked for several major pharmaceutical companies since 1989 on drug discovery projects against schizophrenia, Alzheimer's, diabetes, osteoporosis and other diseases. To contact Derek email him directly: Twitter: Dereklowe

Chemistry and Drug Data: Drugbank
Chempedia Lab
Synthetic Pages
Organic Chemistry Portal
Not Voodoo

Chemistry and Pharma Blogs:
Org Prep Daily
The Haystack
A New Merck, Reviewed
Liberal Arts Chemistry
Electron Pusher
All Things Metathesis
C&E News Blogs
Chemiotics II
Chemical Space
Noel O'Blog
In Vivo Blog
Terra Sigilatta
BBSRC/Douglas Kell
Realizations in Biostatistics
ChemSpider Blog
Organic Chem - Education & Industry
Pharma Strategy Blog
No Name No Slogan
Practical Fragments
The Curious Wavefunction
Natural Product Man
Fragment Literature
Chemistry World Blog
Synthetic Nature
Chemistry Blog
Synthesizing Ideas
Eye on FDA
Chemical Forums
Symyx Blog
Sceptical Chymist
Lamentations on Chemistry
Computational Organic Chemistry
Mining Drugs
Henry Rzepa

Science Blogs and News:
Bad Science
The Loom
Uncertain Principles
Fierce Biotech
Blogs for Industry
Omics! Omics!
Young Female Scientist
Notional Slurry
Nobel Intent
SciTech Daily
Science Blog
Gene Expression (I)
Gene Expression (II)
Adventures in Ethics and Science
Transterrestrial Musings
Slashdot Science
Cosmic Variance
Biology News Net

Medical Blogs
DB's Medical Rants
Science-Based Medicine
Respectful Insolence
Diabetes Mine

Economics and Business
Marginal Revolution
The Volokh Conspiracy
Knowledge Problem

Politics / Current Events
Virginia Postrel
Belmont Club
Mickey Kaus

Belles Lettres
Uncouth Reflections
Arts and Letters Daily
In the Pipeline: Don't miss Derek Lowe's excellent commentary on drug discovery and the pharma industry in general at In the Pipeline

In the Pipeline

« Flibanserin: Not a "Female Viagra" At All | Main | Mylotarg and the FDA »

June 21, 2010

Cease and Desist

Email This Entry

Posted by Derek

In light of recent events around here, I cannot resist posting this. Read and enjoy!

Comments (10) + TrackBacks (0) | Category:


1. J-bone on June 21, 2010 2:31 PM writes...

Well, considering what modern day unicorns are, there could be more trouble ahead for this company.

Permalink to Comment

2. Carl Bussjaeger on June 21, 2010 3:09 PM writes...

Unicorns. Nativis' photon field superwater.

One's about as real as the other.

Permalink to Comment

3. Anon on June 21, 2010 7:27 PM writes...

The only IP partner in that firm's Denver office went to Harvard Law School. I am disappointed.

Permalink to Comment

4. frequent visitor on June 21, 2010 8:37 PM writes...

I am no expert, but behind the sparkles....looks nothing like "the other white meat". That looks like Beef. If they are going to call that white meat, they should have at least used some chicken.

Also if you are going to market Unicorn...those are rare I thought, you are better off getting the rich MBA's fresh out of school, and selling it at the new hip restaurant underground...not in a CAN!

Permalink to Comment

5. frequent visitor on June 21, 2010 8:39 PM writes...

sorry missed the Guinness massaged in daily...that makes

Permalink to Comment

6. JasonP on June 21, 2010 9:37 PM writes...

I can believe in unicorn meat more than magic photonic Star Trek therapy.

Permalink to Comment

7. RandChemist on June 22, 2010 9:54 AM writes...

Unicorns, the favorite meat of marketing departments.

So, ever get the feeling that people work far too hard justifying their jobs?

Permalink to Comment

8. Hap on June 22, 2010 10:10 AM writes...

I wonder if Las Vegas will do a prop bet on whether the unicorn meat or Nativis's cancer therapy will appear on the market first.

Permalink to Comment

9. gained insight on June 22, 2010 1:15 PM writes...

Now I know where marshmallows come from. Always wondered about that..........

Permalink to Comment

10. formerlawyer on June 22, 2010 2:21 PM writes...

In fairness however, Trademarks must be protected less they fall into the public domain.

Xerox (TM) has been fighting an on-going battle with just this issue.

see for example:

Elvis Estate v. Velvet Elvis Bar

Especially at paragraph 46.

The law in this area is difficult.

Permalink to Comment


Remember Me?


Email this entry to:

Your email address:

Message (optional):

The Last Post
The GSK Layoffs Continue, By Proxy
The Move is Nigh
Another Alzheimer's IPO
Cutbacks at C&E News
Sanofi Pays to Get Back Into Oncology
An Irresponsible Statement About Curing Cancer
Oliver Sacks on Turning Back to Chemistry